ChemFeeds Site Navigation:
Journal Selection:
Search:

1) A Pragmatic Definition of Therapeutic Synergy (Molecular Cancer Therapeutics) Monday July 7th 2014


2) miR-3607 in Prostate Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


3) miR26b Regulates Cancer Proliferation (Molecular Cancer Therapeutics) Monday July 7th 2014


4) Repositioning Drugs for Renal Cell Cancer Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


5) Mutation Profile of Melanomas Lacking Known Driver Mutations (Molecular Cancer Therapeutics) Monday July 7th 2014


6) BET Bromodomain Inhibition and Pancreatic Cancer Progression (Molecular Cancer Therapeutics) Monday July 7th 2014


7) Antiproliferative Synergism of CK2 and BRAF Inhibitors (Molecular Cancer Therapeutics) Monday July 7th 2014


8) Targeting ER{beta} in SERM-Resistant Breast Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


9) LXR Inhibition of Myeloma Stem Cells (Molecular Cancer Therapeutics) Monday July 7th 2014


10) SIRT1 in the Antitumor Activity of Silybin (Molecular Cancer Therapeutics) Monday July 7th 2014


11) ABT-737 Enhances MEK/mTOR Inhibition-Induced AML Apoptosis (Molecular Cancer Therapeutics) Monday July 7th 2014


12) PIK3R3 Induces EMT, Promoting Metastasis of Colorectal Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


13) MM-121 Combined with Cetuximab in HNSCC Preclinical Models (Molecular Cancer Therapeutics) Monday July 7th 2014


14) Prostate Cancer-Targeted Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


15) Pretargeted RIT of GD2 with an Anti-GD2/DOTA IgG-scFv (Molecular Cancer Therapeutics) Monday July 7th 2014


16) Anti-sEcad mAb-Induced Suppression of Skin SCCs (Molecular Cancer Therapeutics) Monday July 7th 2014


17) Generation of a Canine Anti-EGFR Antibody (Molecular Cancer Therapeutics) Monday July 7th 2014


18) Antibody-Based Delivery of IL2 and Cytotoxics (Molecular Cancer Therapeutics) Monday July 7th 2014


19) Targeting Pancreatic Cancer Stem Cells (Molecular Cancer Therapeutics) Monday July 7th 2014


20) Effect of Metronomic Docetaxel in PRINT Particles and siEZH2 (Molecular Cancer Therapeutics) Monday July 7th 2014


21) Redox-Active Cerium Oxide Nanoparticles in Cancer Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


22) Anti-miR182 Treatment in Ovarian Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


23) GGA Exerts Cardioprotective and Anticancer Effects (Molecular Cancer Therapeutics) Monday July 7th 2014


24) EW-7197, an Antimetastatic Drug in Breast Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


25) Leelamine Inhibits Intracellular Cholesterol Transport (Molecular Cancer Therapeutics) Monday July 7th 2014


26) Targeting Melanomas Using Leelamine (Molecular Cancer Therapeutics) Monday July 7th 2014


27) Correction: Characterisation of the Novel Apoptotic and Therapeutic Activities of the Histone Deacetylase Inhibitor Romidepsin (Molecular Cancer Therapeutics) Thursday June 5th 2014


28) Efficacy of Zibotentan in Colorectal Cancer--Response (Molecular Cancer Therapeutics) Thursday June 5th 2014


29) Efficacy of Zibotentan in Colorectal Cancer--Letter (Molecular Cancer Therapeutics) Thursday June 5th 2014


30) 3D Environment in Chemoresistance of GBM Stem-like Cells (Molecular Cancer Therapeutics) Thursday June 5th 2014


31) ABT-737 Mediates Dislocation of ER Luminal Proteins (Molecular Cancer Therapeutics) Thursday June 5th 2014


32) PARP Inhibitors' Off-Target Effects (Molecular Cancer Therapeutics) Thursday June 5th 2014


33) Aflibercept versus Bevacizumab in PDX Colorectal Cancer Tumors (Molecular Cancer Therapeutics) Thursday June 5th 2014


34) MLN4924 DNA-Damaging Agent Combinations (Molecular Cancer Therapeutics) Thursday June 5th 2014


35) KRAS Status Predicts Antifolate Sensitivity (Molecular Cancer Therapeutics) Thursday June 5th 2014


36) Antibody-Drug Con{#x0237}ugate BRAF Inhibitor Combination (Molecular Cancer Therapeutics) Thursday June 5th 2014


37) Akt/Autophagy for Sorafenib Resistance in HCC (Molecular Cancer Therapeutics) Thursday June 5th 2014


38) Significance of the PELP1-mTOR Axis in Endocrine Resistance (Molecular Cancer Therapeutics) Thursday June 5th 2014


39) BAFF-R as Target for Antibody Therapy in ALL (Molecular Cancer Therapeutics) Thursday June 5th 2014


40) Noncytotoxic Treatment of Micrometastases (Molecular Cancer Therapeutics) Thursday June 5th 2014


41) AMG 330, a Novel CD3/CD33 BiTE Antibody (Molecular Cancer Therapeutics) Thursday June 5th 2014


42) Mesothelin-Targeting Antibody-Drug Con{#x0237}ugate (Molecular Cancer Therapeutics) Thursday June 5th 2014


43) Alternol Induces ROS-Dependent Apoptosis (Molecular Cancer Therapeutics) Thursday June 5th 2014


44) Tumor Targeting with Integrin {alpha}v{beta}3 and MMP-2 (Molecular Cancer Therapeutics) Thursday June 5th 2014


45) Immunotherapy for Hepatoma Using a Dual-Function Vector (Molecular Cancer Therapeutics) Thursday June 5th 2014


46) Small Molecule Inhibits ETV1 Acetylation and Function (Molecular Cancer Therapeutics) Thursday June 5th 2014


47) The JNK-MCL-1 Axis Contributes to the Anticancer Activity of MT189 (Molecular Cancer Therapeutics) Thursday June 5th 2014


48) Covalent EGFR Mutant-Selective Inhibitors (Molecular Cancer Therapeutics) Thursday June 5th 2014


49) A Small Molecule Inhibitor of EMT Pathways (Molecular Cancer Therapeutics) Thursday June 5th 2014


50) LY2857785 Is a CDK9 Inhibitor with Preclinical Antitumor Activity (Molecular Cancer Therapeutics) Thursday June 5th 2014


51) Coleusin Factor Restores Differentiation of Osteosarcoma (Molecular Cancer Therapeutics) Thursday June 5th 2014


52) Hec1 Inhibitor against Breast Cancer (Molecular Cancer Therapeutics) Thursday June 5th 2014


53) Inhibitors of Lactate Influx but Not Efflux (Molecular Cancer Therapeutics) Thursday June 5th 2014


54) Moguntinones--New Selective Inhibitors (Molecular Cancer Therapeutics) Thursday June 5th 2014


55) MELK, Key Kinase for Stem Cell Phenotype in Cancer Stem Cells (Molecular Cancer Therapeutics) Thursday June 5th 2014


56) Genomic Alterations of Primary and Recurrent Breast Cancer (Molecular Cancer Therapeutics) Tuesday May 6th 2014


57) Metallothioneins and Zinc Sensitize to Chemotherapy (Molecular Cancer Therapeutics) Tuesday May 6th 2014


58) nEGFR Is a Functional Molecular Target in TNBC (Molecular Cancer Therapeutics) Tuesday May 6th 2014


59) ERBB3 Signaling Promotes Resistance to EGFR Blockade (Molecular Cancer Therapeutics) Tuesday May 6th 2014


60) Cytosine Modifications in MGMT and Temozolomide Sensitivity (Molecular Cancer Therapeutics) Tuesday May 6th 2014


61) GALR2-Induced p38-MAPK Promotes Cytokine Secretion and Tumor (Molecular Cancer Therapeutics) Tuesday May 6th 2014


62) Hand-1 Suppresses Vascular Radiosensitivity (Molecular Cancer Therapeutics) Tuesday May 6th 2014


63) PUMA-Mediated Anticancer Effect of Aurora Kinase Inhibitors (Molecular Cancer Therapeutics) Tuesday May 6th 2014


64) The Role of TMEM98 in Chemoresistance of Hepatocellular Carcinoma (Molecular Cancer Therapeutics) Tuesday May 6th 2014


65) EMT Role in Docetaxel Resistance (Molecular Cancer Therapeutics) Tuesday May 6th 2014


66) The Hh Pathway and IPI-926 in Chondrosarcoma (Molecular Cancer Therapeutics) Tuesday May 6th 2014


67) JAK1/JAK2 Inhibition Suppresses Prostate Cancer Metastases (Molecular Cancer Therapeutics) Tuesday May 6th 2014


68) PIM Kinases Regulate CLL Survival and CXCR4 Surface Levels (Molecular Cancer Therapeutics) Tuesday May 6th 2014


69) Imatinib-Resistant Mast Cells Are Sensitive to Ponatinib (Molecular Cancer Therapeutics) Tuesday May 6th 2014


70) Embelin Reduces Colitis-Associated Tumorigenesis (Molecular Cancer Therapeutics) Tuesday May 6th 2014


71) Regulation of STAT5 Function by BRD2 in Leukemias (Molecular Cancer Therapeutics) Tuesday May 6th 2014


72) Novel Temozolomide Analog for Intracranial Breast Cancer (Molecular Cancer Therapeutics) Tuesday May 6th 2014


73) Olaparib Potentiates SN-38 Sensitivity in Colon Cancer Cells (Molecular Cancer Therapeutics) Tuesday May 6th 2014


74) CML and CXCR4 (Molecular Cancer Therapeutics) Tuesday May 6th 2014


75) BET Protein Antagonist and HDAC Inhibitor against AML (Molecular Cancer Therapeutics) Tuesday May 6th 2014


76) Protein Kinase D: A Novel Target for Colorectal Cancer Therapy (Molecular Cancer Therapeutics) Tuesday May 6th 2014


77) NVP-BYL719 PI3K{alpha} Inhibitor and Predictive Response Modeling (Molecular Cancer Therapeutics) Tuesday May 6th 2014


78) Preclinical PK/PD Evaluation of ON123300 in Brain Tumor (Molecular Cancer Therapeutics) Tuesday May 6th 2014


79) Antiangiogenic Activity of UPARANT (Molecular Cancer Therapeutics) Tuesday May 6th 2014


80) Pharmacodynamics and Antitumor Efficacy of XL765 (SAR245409) (Molecular Cancer Therapeutics) Tuesday May 6th 2014


81) Antitumor Effects of Supercritical Extract of Neem (Molecular Cancer Therapeutics) Tuesday May 6th 2014


82) Centmitor-1 Possesses Antimitotic Properties (Molecular Cancer Therapeutics) Tuesday May 6th 2014


83) PI3K{alpha} and PKC Inhibition Are Synergistic in Uveal Melanoma (Molecular Cancer Therapeutics) Tuesday May 6th 2014


84) Nab-Paclitaxel Combinations with Antiangiogenic Agents (Molecular Cancer Therapeutics) Tuesday May 6th 2014


85) Differentiating PI3K/AKT/mTOR Pathway Inhibitors (Molecular Cancer Therapeutics) Tuesday May 6th 2014


86) PPAR-{beta}/{delta} Inhibits Human Breast Cancer Tumorigenicity (Molecular Cancer Therapeutics) Sunday April 6th 2014


87) Targeting Malignant Brain Tumors (Molecular Cancer Therapeutics) Sunday April 6th 2014


88) Single-Cell Pharmacokinetics of PARP Inhibitors (Molecular Cancer Therapeutics) Sunday April 6th 2014


89) Decreased miR-340 in Bone Marrow of Metastatic CRC (Molecular Cancer Therapeutics) Sunday April 6th 2014


90) MSC Promote Tumor Cell Survival (Molecular Cancer Therapeutics) Sunday April 6th 2014


91) Antiglioma Activity of Interferon-{beta} (Molecular Cancer Therapeutics) Sunday April 6th 2014


92) PP2A Inhibition in Colorectal Cancer (Molecular Cancer Therapeutics) Sunday April 6th 2014


93) Archazolid Induces Anoikis in Metastatic Cancer Cells (Molecular Cancer Therapeutics) Sunday April 6th 2014


94) A Neutralizing Anti-LGALS3BP Antibody (Molecular Cancer Therapeutics) Sunday April 6th 2014


95) EMP2 Is a Novel Therapeutic Target in Breast Cancer (Molecular Cancer Therapeutics) Sunday April 6th 2014


96) Antitumor Activity of the Glutaminase Inhibitor CB-839 in TNBC (Molecular Cancer Therapeutics) Sunday April 6th 2014


97) AMG 925, a FLT3/CDK4 Dual Inhibitor for Treating AML (Molecular Cancer Therapeutics) Sunday April 6th 2014


98) Preclinical Activity of Birinapant, a Bivalent SMAC Mimetic (Molecular Cancer Therapeutics) Sunday April 6th 2014


View: prev | next

#RealTimeChem:

Announcements:

Chem News Feed:

Optical Method Measures Graphene Quality

Reflections on seeing a picture of an empty lab

ACS Launches New Journal On Biomaterials

The complex truth about "smart" drugs

Virtual Art Conservation

More details on the University of Minnesota explosion and response

Abandoned Pharma

Arnold Thackray Turns 75: Celebrate with Some Atoms of History

Gold-Catalyzed Synthesis of Carbazoles: Mild and Simple

U.S. Brings Home Gold

New Pipette Picks Up Single Cells

But, I can still see it…. gross.

Oil sands process water may not harm ducks physiologically, but...

Listen like a fly on the wall

Busy this morning


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()